Astex Announces IND Approval for Novel Cancer Drug AT7519


CAMBRIDGE, U.K., June 27, 2005 (PRIMEZONE) -- Astex Technology Ltd.:

 -- Astex announces FDA approval of IND application for novel
    cancer drug
 -- AT7519 went from first synthesis to IND approval in just 14
    months -- twice as fast as industry standard
 -- AT7519 has recently received CTA approval

Full press release attached below:


Contact Data